[This review was originally posted at the Nieman Journalism Lab on March 7, 2014.] Flipboard buys its rival from CNN: Flipboard, […]
[This review was originally posted at the Nieman Journalism Lab on March 29, 2013.] Big paywall announcements in U.K.: As […]
[This review was originally posted at the Nieman Journalism Lab Tramadol Price, on June 29, 2012.]
News Corp. undertakes historic split: In a move that's been predicted for at least a year or two, News Corp. took a drastic step this week to try to contain the damage from its phone hacking/bribery scandal by splitting its news and entertainment properties into separate companies. Its news company will include all of its newspapers in Britain, the U.S., and Australia as well as its Dow Jones newswire and HarperCollins book publishing; the entertainment company will include 20th Century Fox, the Fox TV channel, Tramadol trusted pharmacy reviews, Fox News, other cable channels, and BSkyB and other satellite TV properties. The Murdoch family will retain about a 40% share in both companies.
Wall Street loved the idea, with News Corp.'s shares jumping at the news that the company was discussing a split, Tramadol Price. The reason, as The New York Times' Dealbook explained, Tramadol cost, is that it could free News Corp. from what's known as the "Murdoch discount" — the depressed value of the company because of Rupert Murdoch's influence. Splitting news and entertainment, the thinking goes, frees entertainment to make more money without being weighed down by the newspaper division.
That, said Ryan Chittum of the Columbia Journalism Review, might harm the newspapers just as it helps the entertainment properties, Tramadol pics. Tramadol Price, The Guardian's Michael Wolff contended that the newspapers will lose the upside of being tied to the entertainment side, but keep the downside of being tied to Murdoch. As Reuters' Felix Salmon put it, "Up until now, Murdoch has never really needed to worry very much about his newspapers’ profitability, because the rest of his empire was throwing off such enormous profits. That’s going to change." According to Ad Age, though, What is Tramadol, News Corp.'s papers might do better on Wall Street than many others.
Murdoch said the split wasn't related to the phone hacking scandal, but pretty much everyone else found that claim preposterous. As Paul Sawers of The Next Web put it, the cracks from the scandal had spread too far. More specifically, according to the Guardian's Roy Greenslade, this allows News Corp, Tramadol Price. to invest in the properties it finds profitable (entertainment/BSkyB), and dump the liabilities (British newspapers). Here at the Lab, Tramadol dangers, Ken Doctor said the split will work out quite well for the Murdochs — investors will be happier, and Rupert can still play newspaperman while clearing the way for further entertainment domination.
As for what the move means more specifically, paidContent's Staci Kramer has a good rundown of what it means for each division, and she and the Guardian also looked at who might head up each company. Mathew Ingram of GigaOM urged News Corp. to let the content flow freely across platforms, Taking Tramadol, though Murdoch said his newspapers would be pushed even harder to charge for news online.
A Supreme breaking news error Tramadol Price, : The U.S. Supreme Court's ruling on the Affordable Care Act on Thursday was the occasion for one of the biggest media gaffes of the year, as CNN and Fox News both initially reported erroneously that the act's individual mandate had been found unconstitutional. Both networks issued statements, though only CNN — whose mistake was more prominently displayed and took longer to correct — could be construed as apologizing. Fox claimed it "reported the facts, as they came in," a statement with which both Poynter's Andrew Beaujon and the Washington Post's Erik Wemple took issue, order Tramadol from mexican pharmacy. (Wemple also objected to CNN's explanation of its error.)
The reaction against CNN in particular was quick and relentless: AP reporters were even ordered to stop taunting via social media. Within CNN, as well, the error was anonymously described to BuzzFeed as "shameful," "outrageous," and "humiliating." Rem Rieder of the American Journalism Review said it was a terribly timed stumble for the struggling CNN, and Wemple admonished, "Someone needs to tell CNN: There is no such thing as fashioning a scoop over something that’s released to the public."
Others put the blame within a broader context: The Huffington Post's Jason Linkins described it as a "There but for the grace of God go I" situation for journalists, and the American Copy Editors Society's Charles Apple called it the product of a too-fast media cycle meeting the constantly changing nature of breaking news, Tramadol Price.
Other news orgs reinforced that emphasis on speed: A Washington Post profile on SCOTUSblog, the top destination for instance Supreme Court analysis, noted the site's obsession with getting the news first. Meanwhile, mainstream news orgs fought over who broke the story first (Andrew Beaujon's answer: it depends), Tramadol coupon, and Rem Rieder said that issue is not only unimportant, but harmful to good journalism.
Flipboard and Pulse's models compete for publishers: The New York Times extended its online pay plan this week to include the aggregation app Flipboard, allowing subscribers to access all the Times content there, while limiting nonsubscribers' access to a few free articles. At All Things D, Peter Kafka pointed out that this is the first time the Flipboard has gotten a major publisher to give it full access to its content there, as well as the first time the Times has given out full access to its content through another platform, get Tramadol. Tramadol Price, Kafka also wondered if Flipboard access is really going to add much for Times subscribers, since they already have access to the Times on just about any device they could want. On the other hand, GigaOM's Mathew Ingram liked the idea as a way to acknowledge new ways users are getting news while maintaining control over the pay plan. Jeff Sonderman of Poynter had a few notes for other news orgs, pointing out the Times' statistic that 20% of its readers use aggregation apps and suggesting that this might be a good option for smaller news orgs that can't afford their own extensive app development. And TechCrunch's Alexia Tsotsis weighed in with an angry, drunk anti-Times post. Tramadol natural, At the same time, though, Conde Nast's Wired and The New Yorker announced they're stepping back from Flipboard, giving up selling ads and pulling most of their content. Publishers told Mashable's Lauren Indvik it's just easier (andm more profitable) to sell ads on their site once Flipboard takes its cut, and paidContent's Jeff John Roberts said Flipboard may need to reconsider its revenue-sharing arrangement with publishers, Tramadol Price.
In addition, a day after the Times announced its Flipboard pay plan, the Wall Street Journal announced a similar plan with one of Flipboard's competitors, Pulse, where to buy Tramadol. The Journal's move was part of a strategy shift by Pulse toward paid subscriptions that the company expects to launch it into profitability. Ingram of GigaOM compared Pulse's subscription-based model (which involves subscription revenue sharing and Flipboard's ad-based model — though both are "competing with their publishing clients even as they try to serve them."
Is BuzzFeed stealing ideas?: BuzzFeed, one of the most popular viral content sites on the web, got some scrutiny this week that raised questions in the ongoing discussion about the validity of online aggregation practices. Slate's Farhad Manjoo looked behind the curtain at where BuzzFeed gets the material for its most popular viral posts and found they mostly come from Reddit, with attribution (possibly systematically) stripped. Philip Bump of Grist said Manjoo didn't go far enough Tramadol Price, in his critique, saying that BuzzFeed isn't just aggregating but stealing ideas. Tramadol recreational, But The Atlantic's Derek Thompson pushed back against the BuzzFeed criticism, comparing their raiding Reddit to movie studios grabbing ideas from bestselling books. "BuzzFeed is a hit-maker making hits the only way reliable hits can be made: By figuring out what's already popular and tweaking them to make something new," he wrote.
Reading roundup: A few other smaller stories going on in the background this week:
— Google formally unveiled a number of new products at a press event this week — a streaming media device called the Nexus Q (powered by other Android devices on the same network); a $199 tablet called the Nexus 7; its much-anticipated augmented-reality glasses, Google Glass; and a tablet app for Google+, among a few other things. For some analysis, here's All Things D on the Nexus Q and Google Glass, Tramadol over the counter.
— This week in paywalls: The Chicago Tribune's redesigned website will require registration for some content, a mechanism designed to transition to paid subscriptions. (It's also including some content from the Economist and Forbes in that plan.) U-T San Diego also launched a metered pay plan, and The New York Times will begin charging for crossword puzzles even outside of its subscriptions. Tramadol no rx, Meanwhile, Gannett said its circulation is down but revenue is up at its paywalled papers, and Steve Outing argued against the metered model.
— Two thought-provoking pieces on reinventing journalism, from different perspectives: The Online Journalism Review's Robert Niles on how to reboot newspapers by breaking up the chains, and Technology Review's Christopher Mims on the red flags in many proposals to reinvent journalism (abandoning the news story, lack of knowledge of the business model, vagueness about the medium), after Tramadol.
— Finally, some great pieces here at the Lab this week: An interesting post by Jonathan Stray on how our perception plays into news bias, Clay Shirky on the importance of Gawker's innovation in commenting, and Adrienne LaFrance's illuminating postmortem on The New York Times' involvement with NYU's The Local.
Similar posts: Lipitor Dosage. Cipro Price. Armour Dosage. Japan, craiglist, ebay, overseas, paypal. Buy Glucophage from mexico. Flagyl without prescription.
Trackbacks from: Tramadol Price. Tramadol Price. Tramadol Price. Order Tramadol online overnight delivery no prescription. Tramadol no rx. Buy cheap Tramadol.
[This review was originally posted at the Nieman Journalism Lab Synthroid No Rx, on April 22, 2011.]
Is Flipboard a competitor or collaborator?: Flipboard has quickly become one of the hottest news apps for the iPad, and it continued its streak last week when it announced it had raised $50 million in funding. Flipboard's Mike McCue told All Things Digital's Kara Swisher he'd be using the money to hire more staff and expand onto other devices, including the iPhone and Android platform. But he also talked to TechCrunch about using the money to fend off a rumored competitor in development at Google. (The Houston Chronicle's Dwight Silverman told Google not to bother, because Zite already does the trick for him.)
All this prompted a fantastic analysis of Flipboard from French media consultant Frederic Filloux, buying Synthroid online over the counter, who explained why Flipboard's distinctive user-directed blend of news media sites, RSS feeds, and social media is so wonderful for users but so threatening to publishers. Filloux argued that every media company should be afraid of Flipboard because they've built a superior news-consumption product for users, Where to buy Synthroid, and they're doing it on the backs of publishers. But none of those publishers can complain about Flipboard, because any of them could have (and should have) invented it themselves.
GigaOM's Mathew Ingram advised media companies to be willing to work with Flipboard for a similar "if you can't beat 'em, join 'em" reason: Its app has their apps beat in terms of customizability and usability, so they're better off trying to make money off of it than their own internal options, Synthroid No Rx. ReadWriteWeb's Dan Rowinski wrote about the possibility that Flipboard could be a better alternative partner for publishers than Apple, and Marshall Kirkpatrick wondered why publishers are up in arms about Flipboard in the first place.
Traditional media's personalized news move: One of the reasons that media companies might be less than willing to work with Flipboard is that some of them are building their own personalized news aggregation apps, two of which launched this week: The Washington Post Co.'s Trove and Betaworks' News.me, developed with the New York Times, buy Synthroid without prescription. INFOdocket's Gary Price has the best breakdown of what Trove does: It uses your Facebook account and in-app reading habits to give you personalized "channels" of news, determined by an algorithm and editors' picks — a bit of the "Pandora for news" idea, as the Post's Don Graham called it. (It's free, Synthroid steet value, so it's got that going for it, which is nice.)
All Things Digital's Peter Kafka suspected that Trove will be most useful on mobile media, as its web interface won't be much different from many people's current personalized home pages, and David Zax of Fast Company emphasized the social aspect of the service.
News.me is different from Trove in a number of ways Synthroid No Rx, : It costs 99 cents a week, and it's based not on your reading history, but on what other people on Twitter are reading. (Not just what they're tweeting, but what they're reading — Betaworks' John Borthwick called it reading "over other people's shoulders.") It also pays publishers based on the number of people who read their content through the app, Synthroid duration. That's part of the reason it's gotten the blessing of some media organizations that aren't typically aggregator friendly, like the Associated Press.
Since News.me is based so heavily on Twitter, it raises the obvious question of whether you'd be better off just getting your news for free from Twitter itself. Synthroid mg, That's what Business Insider's Ellis Hamburger wondered, and Gizmodo's Adrian Covert answered a definitive 'no,' though Martin Bryant of The Next Web said it could be helpful in stripping out the chatter of Twitter and adding an algorithmic aspect. GigaOM's Mathew Ingram looked at both services and concluded that they signal a willingness by some traditional media outlets to adjust their longtime broadcasting role to the modern model of the "Daily Me."
A good sign for the Times' pay plan: The overall news from the New York Times Co.'s quarterly earnings report this week wasn't good — net income is down 57% from a year ago — but there was one silver lining for online paid-content advocates: More than 100,000 people have begun paying for the Times' website since it began charging for access last month, Synthroid No Rx. (That number doesn't include those who got free subscriptions via Lincoln, but it does include those who are paying though cheaper introductory trials.)
As Advertising Age's Nat Ives pointed out, there's a lot that number doesn't tell us about traffic and revenue (particularly, where can i cheapest Synthroid online, as paidContent's Staci Kramer noted, how many people are paying full price for their subscriptions), but several folks, including Glynnis MacNicol of Business Insider, Low dose Synthroid, were surprised at how well the Times' pay plan is doing. (Its goal for the first year was 300,000 subscribers.) She said the figure compares favorably with the Financial Times, which got its 200,000th subscriber this year, nine years into its paywall, Synthroid canada, mexico, india.
Those numbers are particularly critical for the Times given the difficulty its company has had over the past several years — as Katie Feola of Adweek wrote, many analysts believe the pay plan is crucial for the Times' financial viability. "But this means the paper's future rests on an untested model that many experts believe can't work in the oversaturated news market," she wrote. "And the Times has to pray the ad market won’t decline faster than analysts predict."
A few other paid-content tidbits: Nine of Slovakia's largest news organizations put up a paywall together this week, and the pope is apparently pro-paywall, Synthroid use, too. At the Guardian, Cory Doctorow mused about how companies can (and can't) get people to pay for the content online in an age of piracy.
Google's hammer falls on eHow: When Google applied its algorithm adjustment last month Synthroid No Rx, to crack down on content farms, Demand Media's eHow actually came out better off (though others didn't fare so well, like the New York Times Co.'s About.com, as we found out this week). Google made a second round of updates last week, and eHow got nailed this time, losing 66% of their Googlejuice, Synthroid from mexico, according to Sistrix.
Search Engine Land's Matt McGee speculated that Google might have actually been surprised when eHow benefited the first time, and may have made this tweak in part as an effort to "correct" that. Demand Media, Synthroid treatment, meanwhile, called Sistrix's eHow numbers"significantly overstated," though the company's stock hit a new low on Monday. Mathew Ingram said investors have reason to worry, as Demand's success seems to be at the mercy of Google's every algorithm tweak.
A Pulitzer first: The Pulitzer Prizes were announced this week, and while the awards were spread pretty broadly among several news organizations, there were a couple of themes to note, Synthroid No Rx. As Felix Salmon and others pointed out, buy generic Synthroid, an abnormally large share of the awards went to business journalism, a trend the Columbia Journalism Review's Dean Starkman opined on in a bit more detail.
The biggest prize from a future-of-news perspective may have gone to ProPublica, whose series on some of the machinations that worsened the financial crisis was the first Pulitzer winner to never appear in print. Purchase Synthroid online, The Lab's Justin Ellis noted that other winners are including significant multimedia components, perhaps signaling a shift in the emphasis of one of journalism's most elite institutions. If you were wondering where WikiLeaks was in all this, well, the New York Times didn't submit its WikiLeaks-based coverage.
Reading roundup Synthroid No Rx, : No huge stories this week, but a few little things that are worth noting:
— Your weekly AOL/Huffington Post update: Jonathan Tasini came out swinging again regarding his lawsuit on behalf of unpaid HuffPo bloggers, Business Insider's Glynnis MacNicol responded in kind, Eric Snider told the story of getting axed from AOL's now-defunct Cinematical blog, and HuffPo unveiled features allowing readers to follow topics and writers.
— Missouri j-school students are chafing against requirements that they buy an iPad (they previously had to buy iPod Touches, canada, mexico, india, and they called that plan a bust). Meanwhile, Ben LaMothe of 10,000 Words had three ideas of social media skills that j-schools should teach.
— Two interesting data points on news innovation: A group led by Daniel Bachhuber put together some fascinating figures about and perspectives from Knight News Challenge grant recipients. And journalism researchers Seth Lewis and Tanja Aitamurto wrote at the Lab about news organizations using open API as a sort of external R&D department.
Similar posts: Order Armour. Glucophage Dosage. Lipitor Mg. Effects of Lipitor. Where can i order Retin A without prescription. Flagyl photos.
Trackbacks from: Synthroid No Rx. Synthroid No Rx. Synthroid No Rx. Synthroid pictures. Synthroid pics. Synthroid overnight.
[This review was originally posted at the Nieman Journalism Lab Flagyl Dosage, on July 30, 2010.]
WikiLeaks, data journalism and radical transparency: I'll be covering two weeks in this review because of the Lab's time off last week, but there really was only one story this week: WikiLeaks' release of The War Logs, a set of 90,000 documents on the war in Afghanistan. There are about 32 angles to this story and I'll try to hit most of them, but if you're pressed for time, the essential reads on the situation are Steve Myers, C.W. Anderson, Clint Hendler and Janine Wedel and Linda Keenan.
WikiLeaks released the documents on its site on Sunday, cooperating with three news organizations — The New York Times, The Guardian and Der Spiegel — to allow them to produce special reports on the documents as they were released. The Nation's Greg Mitchell ably rounded up commentary on the documents' political implications (one tidbit from the documents for newsies: Evidence of the U.S. military paying Afghan journalists to write favorable stories), order Flagyl from mexican pharmacy, as the White House slammed the leaks and the Times for running them, and the Times defended its decision in the press and to its readers.
The comparison that immediately came to many people's minds was the publication of the Pentagon Papers on the Vietnam War in 1971, and two Washington Post articles examined the connection, Flagyl Dosage. (The Wall Street Journal took a look at both cases' First Amendment angles, too.) But several people, most notably ProPublica's Richard Tofel and Slate's Fred Kaplan, quickly countered that the War Logs don't come close to the Pentagon Papers' historical impact. Flagyl pics, They led a collective yawn that emerged from numerous political observers after the documents' publication, with ho-hums coming from Foreign Policy, Mother Jones, the Washington Post, and even the op-ed page of the Times itself. Slate media critic Jack Shafer suggested ways WikiLeaks could have planned its leak better to avoid such ennui.
But plenty of other folks found a lot that was interesting about the entire situation. Flagyl Dosage, (That, of course, is why I'm writing about it.) The Columbia Journalism Review's Joel Meares argued that the military pundits dismissing the War Logs as old news are forgetting that this information is still putting an often-forgotten war back squarely in the public's consciousness. But the most fascinating angle of this story to many of us future-of-news nerds was that this leak represents the entry of an entirely new kind of editorial process into mainstream news, Flagyl description. That's what the Atlantic's Alexis Madrigal sensed early on, and several others sussed out as the week moved along. The Times' David Carr called WikiLeaks' quasi-publisher role both a new kind of hybrid journalism and an affirmation of the need for traditional reporting to provide context. Poynter's Steve Myers made some astute observations about this new kind of journalism, including the rise of the source advocate and WikiLeaks' trading information for credibility. NYU j-prof Jay Rosen noted thatWikiLeaks is the first "stateless news organization," able to shed light on the secrets of the powerful because of freedom provided not by law, but by the web.
Both John McQuaid and Slate's Anne Applebaum emphasized the need for data to be, as McQuaid put it, "marshaled in service to a story, an argument," with McQuaid citing that as reason for excitement about journalism and Applebaum calling it a case for traditional reporting, Flagyl Dosage. Here at the Lab, Low dose Flagyl, CUNY j-prof C.W. Anderson put a lot this discussion into perspective with two perceptive postson WikiLeaks as the coming-out party for data journalism. He described its value well: "In these recent stories, its not the presence of something new, but the ability to tease a pattern out of a lot of little things we already know that’s the big deal."
As for WikiLeaks itself, the Columbia Journalism Review's Clint Hendler provided a fascinating account of how its scoop ended up in three of the world's major newspapers, including differences in WikiLeaks' and the papers' characterization of WikiLeaks' involvement, which might help explain its public post-publication falling-out with the Times, Flagyl over the counter. The Times profiled WikiLeaks and its enigmatic founder, Julian Assange, and several others trained their criticism on WikiLeaks itself — specifically, on the group's insistence on radical transparency from others but extreme secrecy from itself. The Washington Post's Howard Kurtz said WikiLeaks is "a global power unto itself Flagyl Dosage, ," not subject to any checks and balances, and former military reporter Jamie McIntyre called WikiLeaks "anti-privacy terrorists."
Several others were skeptical of Assange's motives and secrecy, and Slate's Farhad Manjoo wondered how we could square public trust with such a commitment to anonymity. In a smart Huffington Post analysis of that issue, Janine Wedel and Linda Keenan presented this new type of news organization as a natural consequence of the new cultural architecture (the "adhocracy, Buy Flagyl from mexico, " as they call it) of the web: "These technologies lend themselves to new forms of power and influence that are neither bureaucratic nor centralized in traditional ways, nor are they generally responsive to traditional means of accountability."
Keeping readers out with a paywall: The Times and Sunday Times of London put up their online paywall earlier this month, the first of Rupert Murdoch's newspapers to set off on his paid-content mission (though some other properties, like The Wall Street Journal, have long charged for online access). Last week, we got some preliminary figures indicating how life behind the wall is going so far: Former Times media reporter Dan Sabbagh said that 150,000 of the Times' online readers (12 percent of its pre-wall visitors) had registered for free trials during the paywall's first two weeks, discount Flagyl, with 15,000 signing on as paying subscribers and 12,500 subscribing to the iPad app. PaidContent also noted that the Times' overall web traffic is down about 67 percent, adding that the Times will probably tout these types of numbers as a success.
The Guardian did its own math and found that the Times' online readership is actually down about 90 percent — exactly in line with what the paper's leaders and industry analysts were expecting. Everyone noted that this is exactly what Murdoch and the Times wanted out of their paywall — to cut down on drive-by readers and wring more revenue out of the core of loyal ones, Flagyl Dosage. Online buying Flagyl hcl, GigaOM's Mathew Ingram explained that rationale well, then ripped it apart, calling it "fundamentally a resignation from the open web" because it keeps readers from sharing (or marketing) it with others. SEOmoz's Tom Critchlow looked at the Times' paywall interface and gave it a tepid review.
Meanwhile, another British newspaper that charges for online access, the Financial Times, is boasting strong growth in online revenue, where to buy Flagyl. The FT's CEO, John Ridding, credited the paper's metered paid-content system and offered a moral argument for paid access online, drawing on Time founder Henry Luce's idea that an exclusively advertising-reliant model weakens the bond between a publication and its readers.
Flipboard and the future of mobile media Flagyl Dosage, : In just four months, we've already seen quite a few attention-grabbing iPad apps, but probably none have gotten techies' hearts racing quite like Flipboard, which was launched last week amid an ocean of hype. As Mashable explained, Flipboard combines social media and news sources of the user's choosing to create what's essentially a socially edited magazine for the iPad. Flagyl photos, The app got rave reviews from tech titans like Robert Scoble and ReadWriteWeb, which helped build up enough demand that it spent most of its first few post-release days crashed from being over capacity.
Jen McFadden marveled at Flipboard's potential for mobile advertising, given its ability to merge the rich advertising experience of the iPad with the targeted advertising possibilities through social media, though Martin Belam wondered whether the app might end up being "yet another layer of disintermediation that took away some of my abilities to understand how and when my content was being used, or to monetise my work." Tech pioneer Dave Winer saw Flipboard as one half of a brilliant innovation for mobile media and challenged Flipboard to encourage developers to create the other half.
At the tech blog Gizmodo, Joel Johnson broke in to ask a pertinent question: Is Flipboard legal, Flagyl maximum dosage. The app scrapes content directly from other sites, rather than through RSS, like the Pulse Reader, Flagyl Dosage. Flipboard's defense is that it only offers previews (if you want to read the whole thing, you have to click on "Read on Web"), but Johnson delved into some of the less black-and-white scenarios and legal issues, too. (Flipboard, for example, Buy generic Flagyl, takes full images, and though it is free for now, its executives plan to sell their own ads around the content under revenue-sharing agreements.) Stowe Boyd took those questions a step further and looked at possible challenges down the road from social media providers like Facebook.
A new perspective on content farms: Few people had heard of the term "content farms" about a year ago, but by now there are few issues that get blood boiling in future-of-journalism circles quite like that one. PBS MediaShift's eight-part series on content farms, published starting last week, is an ideal resource to catch you up on what those companies are, is Flagyl addictive, why people are so worked up about them, and what they might mean for journalism. Flagyl Dosage, (MediaShift defines "content farm" as a company that produces online content on a massive scale; I, like Jay Rosen, would define it more narrowly, based on algorithm- and revenue-driven editing.)
The series includes an overview of some of the major players on the online content scene, pictures of what writing for and training at a content farm is like, and two posts on the world of large-scale hyperlocal news. It also features an interesting defense of content farms by Dorian Benkoil, who argues that large-scale online content creators are merely disrupting an inefficient, expensive industry (traditional media) that was ripe for a kick in the pants.
Demand Media's Jeremy Reed responded to the series with a note to the company's writers that "You are not a nameless, Buying Flagyl online over the counter, faceless, soul-less group of people on a 'farm.' We are not a robotic organization that’s only concerned about numbers and data. We are a media company. We work together to tell stories," and Yahoo Media's Jimmy Pitaro defended the algorithm-as-editor model in an interview with Forbes. Outspoken content-farm critic Jason Fry softened his views, too, urging news organizations to learn from their algorithm-driven approach and let their audiences play a greater role in determining their coverage, Flagyl Dosage.
Reading roundup: A few developments and ideas to take a look at before the weekend:
— We've written about the FTC's upcoming report on journalism and public policy earlier this summer, and Google added its own comments to the public record last week, urging the FTC to move away from "protectionist barriers." Google-watcher Jeff Jarvis gave the statement a hearty amen, and the Boston Globe's Jeff Jacoby chimed in against a government subsidy for journalism.
— Former equity analyst Henry Blodget celebrated The Business Insider's third birthday with a very pessimistic forecast of The New York Times' future, and, by extension, the traditional media's as well. Meanwhile, Judy Sims targeted a failure to focus on ROI as a cause of newspapers' demise.
— The Columbia Journalism Review devoted a feature to the rise of private news, in which news organizations are devoted to a niche topic for an intentionally limited audience.
Similar posts: Cephalexin Price. Glucophage For Sale. Cephalexin Dosage. Herbal Tramadol. Cephalexin interactions. Cephalexin overnight.
Trackbacks from: Flagyl Dosage. Flagyl Dosage. Flagyl Dosage. Where can i buy Flagyl online. Flagyl dangers. Comprar en línea Flagyl, comprar Flagyl baratos.